Serum-derived MHC class II molecules: Potent regulators of the cellular and humoral immune response

Immunobiology

Volumn 215, Issue 3, 2010, Pages 194-205

  Marios Frankiskos, Sardis ^a   Panagiota, Miltiadou ^a   Katerina, Bakela ^a   Athanassakis, Irene ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Cellular immune response; Cytokines; Humoral immune response; Mitogenic response; Soluble MHC class II

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HERMES ANTIGEN; IMMUNOGLOBULIN M; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE ANTIGEN; NEUTRALIZING ANTIBODY; PROTEIN ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PURIFICATION; ANTIGEN SPECIFICITY; ARTICLE; CELL ACTIVITY; CELL POPULATION; CELL PROLIFERATION; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMORAL IMMUNITY; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; IMMUNOREGULATION; LEGIONELLA PNEUMOPHILA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TARGET CELL; TH1 CELL; TH2 CELL;

ANIMALS; B-LYMPHOCYTES; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HLA-D ANTIGENS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICROSCOPY, CONFOCAL;

EID: 77949262396     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2009.04.005     Document Type: Article

References (29)

1. Amigonera S., Webster P., Drake J., Newcomb J., Cresswell P., and Mellman I. Invariant chain cleavage and peptide loading in major histocompatibility complex class 1I vesicles. J. Exp. Med. 181 (1995) 1729-1741
2. Athanassakis I., and Iconomidou B. Cytokine production in the serum and spleen of mice from day 6 to 14 of gestation. Dev. Immunol. 4 (1996) 247-255
3. Athanassakis I., Ranella A., and Vassiliadis S. IFN-γ facilitates release of class II-loaded intracellular pools in trophoblast cells: a novel property independent of protein synthesis. J. Interferon Cytokine Res. 20 (2000) 823-830
4. Athanassakis I., and Vassiliadis S. T-regulatory cells: are we re-discovering T suppressors?. Immunol. Lett. 84 (2002) 173-179
5. Aultman D., Adamashvili I., Yaturu K., Langford M., Gelder F., Gautreaux M., Ghali G.E., and McDonald J. Soluble HLA in human body fluids. Hum. Immunol. 60 (1999) 239-244
6. Calne R.Y., White H.J., Yoffa D.E., Binns R.M., Maginn R.R., Herbertson R.M., Millard P.R., Molina V.P., and Davis D.R. Prolonged survival of liver transplants in the pig. Br. Med. J. 4 (1967) 645-648
7. Chaves F.A., Hou P., Wu S., and Sant A.J. Replacement of the membrane proximal region of I-Ad MHC class II molecule with I-E-derived sequences promotes production of an active and stable soluble heterodimer without altering peptide-binding specificity. J. Immunol. Methods 300 (2005) 74-92
8. Fischer U.B., Jacovetty E.L., Medeiros R.B., Goudy B.D., Zell T., Swanson J.B., Lorenz E., Shimizu Y., Miller M.J., Khoruts A., and Ingulli E. MHC class II deprivation impairs CD4 T cell motility and responsiveness to antigen-bearing dendritic cells in vivo. Proc. Natl. Acad. Sci. USA 104 (2007) 7181-7186
9. + T cells through transfer of the peptide to T cell MHC molecules. Proc. Natl. Acad. Sci. USA 99 (2002) 13729-13734
10. Ghio M., Contini P., Mazzei C., Brenci S., Barberis G., Filaci G., Indiveri F., and Puppo F. Soluble HLA class I, HLA class II, and Fas ligand in blood components: a possible key to explain the immunomodulatory effects of allogeneic blood transfusions. Blood 93 (1999) 1770-1777
11. Hagihara M., Shimura T., Yamamoto K., Takebe K., Munkhbat B., and Tsuji K. Soluble HLA Class I and Class II in Japanese. Hum. Immunol. 40 (1994) 171-173
12. Kappler J.W., Skidmore B., White J., and Marrack P. Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition. J. Exp. Med. 153 (1981) 1198-1214
13. Karin M., and Lin A. NF-kappaB at the crossroads of life and death. Nat. Immunol. 3 (2002) 221-227
14. Krogsgaard M., and Davis M.M. How T cells 'see' antigen. Nat. Immunol. 6 (2005) 239-245
15. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 277 (1970) 680-685
16. Nag B., Kendrick T., Arimilli S., Yu S.C.T., and Sriram S. Soluble MHC II-peptide complexes induce antigen-specific apoptosis in T cells. Cell. Immunol. 170 (1996) 25-33
17. Nel A.E., and Slaughter N. T-cell activation through the antigen receptor. Part 2: Role of signaling cascades in T-cell differentiation, anergy, immune senescence, and development of immunotherapy. J. Allergy Clin. Immunol. 109 (2002) 901-915
18. Pfeiffer K.A., Rebmann V., Passler M., van der Ven K., van der Ven H., Krebs D., and Grosse-Wilde H. Soluble HLA levels in early pregnancy after in vitro fertilization. Hum. Immunol. 61 (2000) 559-564
19. Puppo F., Indiveri F., Scudeletti M., and Femme S. Soluble HLA antigens: new roles and uses. Trends Immunol. 18 (1997) 154-155
20. Ranella A., Vassiliadis S., Mastora C., Dionyssopoulou E., and Athanassakis I. Constitutive intracellular expression of human leukocyte antigen (HLA)-DO and HLA-DR but not HLA-DM in trophoblast cells. Hum. Immunol. 66 (2005) 43-55
21. Rizzo R., Mapp C.E., Melchiorri L., Maestrelli P., Visentin A., Ferretti S., Bononi I., Miotto D., and Baricordi O.R. Defective production of soluble HLA-G molecules by peripheral blood monocytes in patients with asthma. J. Allergy Clin. Immunol. 115 (2004) 508-513
22. Siebenlist U., Brown K., and Claudio E. Control of lymphocyte development by nuclear factor-kappaB. Nat. Rev. Immunol. 5 (2005) 435-445
23. Steinborn A., Rebmann V., Scharf A., Sohn C., and Grosse-Wilde H. Soluble HLA-DR levels in the maternal circulation of normal and pathologic pregnancy. Am. J. Obstet. Gynecol. 188 (2003) 473-479
24. Vassiliadis S., Paflis M., and Athanassakis I. Serum-soluble HLA class I and class II levels as an alternative diagnostic test for determining immune indexes required for normal pregnancies. Reprod. Fertil. Dev. 13 (2001) 427-433
25. Verbruggen L.A., Dumarey N., van de Velde H., Rebmann V., Flament J., van Wayenberge C., Grosse-Wilde H., and Demanet C. Soluble HLA-DR antigen levels in serum correlate with rheumatoid arthritis disease activity and the presence of disease-associated epitopes. Tissue Antigens 56 (2000) 436-440
26. van Rood J.J., van Leeuwen A., and van Santen M.C.T. Anti-HL-A2 inhibitor in normal human serum. Nature 226 (1970) 366-367
27. Verbruggen L.A., Versaen H., Rebmann V., Duquet W., De Cock S., Grosse-Wilde H., and Demanet C. Soluble HLADR Levels in serum are associated with therapy and genetic factors in rheumatoid arthritis. Hum. Immunol. 63 (2002) 758-764
28. Webb B.J., Bochan M.R., Montel A., Padilla L.M., and Brahmi Z. The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum. Cell Immunol. 159 (1994) 246-261
29. Wolf R.E., Adamashvili I.M., Gelder F.B., Hall V.C., Fraser P.A., and McDonald J.C. Soluble HLA-I in rheumatic diseases. Hum. Immunol. 59 (1998) 644-649